Live Cell Encapsulation Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028, Segmented By Polymer Type (Alginate, Chitosan, Cellulose Sulphate and Others), By Application (Drug Delivery, Regenerative Medicine, Cell Transplantation and Probiotics), By Technique (Simple Dripping, Electrostatic Dripping and Coaxial Airflow), By Region

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Live Cell Encapsulation Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028.  This can be attributed to factors such as growing research & development in improving the effectiveness of cell encapsulation technologies, along with the rise in governmental and private investments supporting live cell encapsulated product development.

Live cell encapsulation is a bioengineering technology which includes encasing living cell with a material or coating. A distinct variety of materials are used for the encapsulation such as liposomes, hydrogels, and microcapsules.

Moreover, live cell encapsulation is found to have significant importance in cell therapies as it allows a controlled release of bioactive material or cells, and thereby is anticipated to bolster the market growth with rise in cell therapies across the globe.

 Increase in Cell Therapies

The live cell encapsulation delivers the medicinal cell component or bioactive materials in a controlled manner and thus is efficient to be used in cell therapies as they include the delivery of therapeutics directly in the targeted location in the body. Additionally, they do not create any response by the body’s immune system and thus aren’t attacked or eliminated by the immune system. The encapsulates cells in cases carry out specific functions such as activating cancer drugs. For instance, in 2021, a company Nuvilex performed a research study in which the live cells were encapsulated within beads to treat pancreatic cancer. It was observed the cells converted the inactive cancer drug ifosfamide into its cancer-killing form and this specific property ensures the delivery of the chemotherapeutic drug directly to the tumor and thereby is found to have potential usage in the future.

Rising Prevalence of Chronic Disease

Chronic disease such as cancer, diabetes, etc. are rising across the globe and are a major health concern worldwide. According to the report by the International Diabetes Foundation, in 2021 round 537 million adults were affected by diabetes, and it is expected to increase to 643 million by 2030, and by 2045, it will reach 783 million. The introduction and increased awareness about the applications of live cell encapsulation in treatment of chronic diseases such as type 1 diabetes, cancer, and autoimmune diseases is expected to boost the market. For instance, the live cell encapsulation technology is used for delivering insulin producing cells to the patient suffering from type 1 diabetes and dopamine delivering in case of Parkinson’s disease. Thus, the growing number of chronic diseases is creating a huge demand for companies to include and enhance live cell encapsulation and thereby is expected to bolster the market growth in the forecast period.

Growing Research & Development to Improve Product Efficacy

Growing expansion of biotechnology with increasing research & development and rising company investments in live cell encapsulation technologies is leading to improvement in the development and clinical efficacy of live cell encapsulation. The growing investment and increased mutual associations to enhance the live cell encapsulation technological application and production by the key market players is further contributing to the growth of global live cell encapsulation market. For instance, In November 2022, a leading supplier of biocompatible materials- BIO INX collaborated with Nanoscribe- a microfabrication technology leader and introduced HYDROBIO INX N400- that enables cell encapsulation in high resolution i.e., 3D printing and is especially designed for 3D microfabrication. Additionally, in July 2021, a clinical biotechnology company -PharmaCyte Biotech developed targeted treatments for cancer and diabetes using live-cell encapsulation technique and has commenced the first phase of a two-phase pig study used for investigating live cell encapsulation technology for diabetes treatment. Thus, growing research are providing opportunities for the companies to enhance the live cell encapsulation technique.


Download Free Sample Report

Market Segmentation

Global Live Cell Encapsulation Market is segmented based on polymer type, application, technique, region and competitive landscape. Based on polymer type, the market is segmented into alginate, chitosan, cellulose sulfate, and others. Based on application, the market is segmented into drug delivery, regenerative medicine, cell transplantation and probiotics. Based on technique, the market is segmented into simple dripping, electrostatic dripping, and coaxial airflow. Based on the region, the market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

AUSTRIANOVA, Merck KGaA, Sphere Fluidics Ltd., ViaCyte, Inc., Blacktrace Holdings Ltd. (Dolomite Microfluidics), BIO INX, Living Cell Technologies Ltd., Sigilon Therapeutics, Inc.,Isogen, Diatranz Otsuka Ltd. are some of the major players operating in the Global Live Cell Encapsulation Market.

Attribute

Details

Base Year

2022

Historical Years

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

Polymer Type

Application

Technique

Regional Scope

North America; Asia Pacific; Europe; South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa; Kuwait

Key Companies Profiled

AUSTRIANOVA, Merck KGaA, Sphere Fluidics Ltd., ViaCyte, Inc., Blacktrace Holdings Ltd. (Dolomite Microfluidics), BIO INX, Living Cell Technologies Ltd., Sigilon Therapeutics, Inc.,Isogen, Diatranz Otsuka Ltd.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, Global Live Cell Encapsulation Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Live Cell Encapsulation Market, By Polymer Type:
    • Alginate
    • Chitosan
    • Cellulose Sulfate
    • Others
  • Live Cell Encapsulation Market, By Application:
    • Drug Delivery
    • Regenerative Medicine
    • Cell Transplantation
    • Probiotics
  • Live Cell Encapsulation Market, By Technique:
    • Simple Dripping
    • Electrostatic Dripping
    • Coaxial Airflow
  • Live Cell Encapsulation Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Live Cell Encapsulation Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional Market players (up to five).

Cell Dissociation Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered.

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Live Cell encapsulation Market Outlook.

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Polymer Type (Alginate, Chitosan, Cellulose Sulfate and Others)

5.2.2.    By Application (Drug Delivery, Regenerative Medicine, Cell Transplantation and Probiotics)

5.2.3.    By Technique (Simple Dripping, Electrostatic Dripping and Coaxial Airflow

5.2.4.    By Company (2022)

5.2.5.    By Region

5.3.  Product Market Map

6.    Asia-Pacific Live Cell encapsulation Market Outlook

6.1.  Market Size & Forecast       

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    Polymer Type

6.2.2.    Application

6.2.3.    Technique

6.2.4.    By Country

6.3.  Asia-Pacific: Country Analysis

6.3.1.    China Live Cell encapsulation Market Outlook.

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.           By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.           Polymer Type

6.3.1.2.2.           Application

6.3.1.2.3.           Technique

6.3.2.    India Live Cell encapsulation Market Outlook.

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.           By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.           Polymer Type

6.3.2.2.2.           Application

6.3.2.2.3.           Technique

6.3.3.    South Korea Live Cell encapsulation Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.           By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.           Polymer Type

6.3.3.2.2.           Application

6.3.3.2.3.           Technique

6.3.4.    Japan Live Cell encapsulation Market Outlook

6.3.4.1.        Market Size & Forecast

6.3.4.1.1.           By Value

6.3.4.2.        Market Share & Forecast

6.3.4.2.1.           Polymer Type

6.3.4.2.2.           Application

6.3.4.2.3.           Technique

6.3.5.    Australia Live Cell encapsulation Market Outlook

6.3.5.1.        Market Size & Forecast

6.3.5.1.1.           By Value

6.3.5.2.        Market Share & Forecast

6.3.5.2.1.           Polymer Type

6.3.5.2.2.           Application

6.3.5.2.3.           Technique

7.    Europe Live Cell encapsulation Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    Polymer Type

7.2.2.    Application

7.2.3.    Technique

7.2.4.    By Country

7.3.  Europe: Country Analysis

7.3.1.    France Live Cell encapsulation Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           Polymer Type

7.3.1.2.2.           Application

7.3.1.2.3.           Technique

7.3.2.    Germany Live Cell encapsulation Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           Polymer Type

7.3.2.2.2.           Application

7.3.2.2.3.           Technique

7.3.3.    United Kingdom Live Cell encapsulation Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           Polymer Type

7.3.3.2.2.           Application

7.3.3.2.3.           Technique

7.3.4.    Italy Live Cell encapsulation Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.           By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.           Polymer Type

7.3.4.2.2.           Application

7.3.4.2.3.           Technique

7.3.5.    Spain Live Cell encapsulation Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.           By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.           Polymer Type

7.3.5.2.2.           Application

7.3.5.2.3.           Technique

8.    North America Live Cell encapsulation Market Outlook.

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    Polymer Type

8.2.2.    Application

8.2.3.    Technique

8.2.4.    By Country

8.3.  North America: Country Analysis

8.3.1.    United States Live Cell encapsulation Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           Polymer Type

8.3.1.2.2.           Application

8.3.1.2.3.           Technique

8.3.2.    Mexico Live Cell encapsulation Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           Polymer Type

8.3.2.2.2.           Application

8.3.2.2.3.           Technique

8.3.3.    Canada Live Cell encapsulation Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           Polymer Type

8.3.3.2.2.           Application

8.3.3.2.3.           Technique

9.    South America Live Cell encapsulation Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    Polymer Type

9.2.2.    Application

9.2.3.    Technique

9.2.4.    By Country

9.3.  South America: Country Analysis

9.3.1.    Brazil Live Cell encapsulation Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           Polymer Type

9.3.1.2.2.           Application

9.3.1.2.3.           Technique

9.3.2.    Argentina Live Cell encapsulation Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           Polymer Type

9.3.2.2.2.           Application

9.3.2.2.3.           Technique

9.3.3.    Colombia Live Cell encapsulation Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           Polymer Type

9.3.3.2.2.           Application

9.3.3.2.3.           Technique

10. Middle East and Africa Live Cell encapsulation Market Outlook

10.1.             Market Size & Forecast        

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. Polymer Type

10.2.2. Application

10.2.3. Technique

10.2.4. By Country

10.3.             MEA: Country Analysis

10.3.1. South Africa Live Cell encapsulation Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         Polymer Type

10.3.1.2.2.         Application

10.3.1.2.3.         Technique

10.3.2. Saudi Arabia Live Cell encapsulation Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         Polymer Type

10.3.2.2.2.         Application

10.3.2.2.3.         Technique

10.3.3. UAE Live Cell encapsulation Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         Polymer Type

10.3.3.2.2.         Application

10.3.3.2.3.         Technique

10.3.4. Kuwait Live Cell encapsulation Market Outlook

10.3.4.1.     Market Size & Forecast

10.3.4.1.1.         By Value

10.3.4.2.     Market Share & Forecast

10.3.4.2.1.         Polymer Type

10.3.4.2.2.         Application

10.3.4.2.3.         Technique

11. Market Dynamics

11.1.             Drivers

11.2.             Challenges

12. Market Trends & Developments

12.1.             Recent Developments

12.2.             Mergers & Acquisitions

12.3.             Product Developments

13. Competitive Landscape

13.1.             Business Overview

13.2.             Company Snapshot

13.3.             Products & Services

13.4.             Financials (In case of listed companies)

13.5.             Recent Developments

13.6.             SWOT Analysis

13.6.1.  AUSTRIANOVA

13.6.2.   Merck KGaA

13.6.3.  Sphere Fluidics Ltd.

13.6.4.  ViaCyte, Inc.

13.6.5.  Blacktrace Holdings Ltd. (Dolomite Microfluidics)

13.6.6.  BIO INX

13.6.7.   Living Cell Technologies Ltd.

13.6.8.   Sigilon Therapeutics, Inc.

13.6.9.  Isogen

13.6.10.   Diatranz Otsuka Ltd.

Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The rising demand for live cell encapsulation in treatment of chronic diseases, increasing investments for research & development for enhancing the technology, etc., are factors driving the growth of the Global Live Cell Encapsulation Market in the forecast years, 2024-2028.

down-arrow

AUSTRIANOVA, Merck KGaA, Sphere Fluidics Ltd., ViaCyte, Inc., Blacktrace Holdings Ltd. (Dolomite Microfluidics), BIO INX, Living Cell Technologies Ltd., Sigilon Therapeutics, Inc.,Isogen, Diatranz Otsuka Ltd. are some of the leading companies in the Global Live Cell encapsulation Market.

down-arrow

North America dominates the Global Live Cell Encapsulation Market on account of increased awareness leading to higher demand for live encapsulation techniques in treatment of disease and increased research & development for improving the live encapsulation techniques in the region.

down-arrow

The high cost and hectic and precise use of live cell encapsulation are some of the key factors hampering the growth of Global Live Cell Encapsulation Market in the forecast period.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Live Cell Encapsulation Market to be Dominated by drug delivery Segment by 2028

May, 2023

Rising private and governmental investments to enhance live cell encapsulation technology are expected to drive the Global Live Cell Encapsulation Market in the forecast period, 2024-2028.

Why Choose Us